Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 87 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  2. US 7964186

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  3. US 7955596

    B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production

    UNIVERSITY OF CONNECTICUT · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted

  4. US 7951356

    Tissue factor compositions and kits for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted

  5. US 7951543

    Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

    SureGene LLC · Granted May 31, 2011 · Expires May 26, 2031

    granted

  6. US 7943318

    Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 17, 2011 · Expires May 12, 2031

    granted

  7. US 7922999

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  8. US 7923004

    4-ethynyl pyrazole derivative compounds and methods for treatment of HCV

    XTL BIOPHARMACEUTICALS LTD. · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  9. US 7919246

    SEMA4D in cancer diagnosis, detection and treatment

    Sagres Discovery, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  10. US 7919088

    Treatment and delay of onset of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  11. US 7919496

    Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  12. US 7914780

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  13. US 7915240

    Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

    OM PHARMA · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  14. US 7910546

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  15. US 7906555

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  16. US 7902241

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  17. US 7897575

    Treatment and prevention of vascular dementia

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  18. US 7893027

    Treatment of ocular wounds and ulcers

    The Board of Regents of the University of Oklahoma · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  19. US 7892777

    Methods for measuring whether a treatment affects RPTP-κ activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  20. US 7879334

    Fusion molecules and treatment of IgE-mediated allergic diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  21. US 7879324

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  22. US 7875598

    Compositions useful for the treatment of microbial infections

    The Regents of the University of California · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  23. US 7872110

    Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  24. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.